Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study

Targeted axillary dissection (TAD) includes biopsy of clipped lymph node and sentinel lymph nodes. However, clinical evidence regarding clinical feasibility and oncological safety of non-radioactive TAD in a real-world cohort remains limited. METHODS: In this prospective registry study, patients rou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Si-Yu, Li, Jian-Wei, Wang, Yu-Jie, Jin, Kai-Rui, Yang, Ben-Long, Li, Jun-Jie, Yu, Xiao-Li, Mo, Miao, Hu, Na, Shao, Zhi-Ming, Liu, Guang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389616/
https://www.ncbi.nlm.nih.gov/pubmed/37132193
http://dx.doi.org/10.1097/JS9.0000000000000331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389616/
https://www.ncbi.nlm.nih.gov/pubmed/37132193
http://dx.doi.org/10.1097/JS9.0000000000000331

Ejemplares similares